Skip to content

Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen

Urios P, Grigorova-Borsos A, Sternberg M ...see all

Diabetes Research and Clinical Practice, vol. 77, issue 2 (2007) pp. 337-340

  • 10


    Mendeley users who have this article in their library.
  • 27


    Citations of this article.
  • 1.0k


    ScienceDirect users who have downloaded this article.
Sign in to save reference


Aspirin showed an inhibitory effect on the formation of pentosidine, a cross-linking advanced glycation endproduct, in collagen incubated with glucose in vitro. IC50 was evaluated at 10 mmol/l. Aspirin might act by metallic ion chelating (as did EDTA and DTPA) and by oxygen radical scavenging. Since aspirin was reported to inhibit retinopathy in diabetic dogs, it could act partly by inhibiting advanced glycation endproduct accumulation in long-lived proteins like collagens. © 2007 Elsevier Ireland Ltd. All rights reserved.

Author-supplied keywords

  • Advanced glycation endproducts (AGEs)
  • Aspirin
  • Collagens
  • Pentosidine
  • Salicylates

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • P. Urios

  • A. M. Grigorova-Borsos

  • M. Sternberg

Cite this document

Choose a citation style from the tabs below